期刊文献+

MELD评分系统对乙型肝炎后肝硬化失代偿期患者预后预测的应用价值 被引量:1

暂未订购
导出
摘要 目的研究终末期肝病模型(MELD)评分系统对乙型肝炎(简称乙肝)后肝硬化失代偿期患者1年预后的预测价值。方法应用MELD评分系统及Child-Pugh分级对l64例乙肝后肝硬化失代偿期患者进行评分及分级,并作比较。结果31例患者在1年内死亡;MELD分值≥18分患者1年的病死率为69.23%,明显高于<18分患者的14.57%,差异有统计学意义(P<0.001);Child-PughA、B、C级患者1年的病死率分别为3.23%、14.29%、36.73%,三组间差异有统计学意义(P<0.001)。MELD的ROC曲线下面积为0.801(95%0.722~0.873),Child-Pugh为0.772(95%0.689~0.854)。结论MELD评分系统对乙肝后肝硬化失代偿期患者1年的预后判断有很重要的价值。
作者 张玉 屈小勤
机构地区 浙江省台州医院
出处 《现代实用医学》 2010年第1期32-33,共2页 Modern Practical Medicine
  • 相关文献

参考文献4

二级参考文献38

  • 1[29]Filsoufi F,Salzberg SP,Rahmanian PB,Schiano TD,Elsiesy H,Squire A,Adams DH.Early and late outcome of cardiac surgery in patients with liver cirrhosis.Liver Transpl 2007; 13:990-995
  • 2[30]Eagle KA,Berger PB,Calkins H,Chaitman BR,Ewy GA,Fleischmann KE,Fleisher LA,Froehlich JB,Gusberg RJ,Leppo JA,Ryan T,Schlant RC,Winters WL Jr,Gibbons RJ,Antman EM,Alpert JS,Faxon DP,Fuster V,Gregoratos G,Jacobs AK,Hiratzka LF,Russell RO,Smith SC Jr.ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).Circulation 2002; 105:1257-1267
  • 3[1]Friedman LS.The risk of surgery in patients with liver disease.Hepatology 1999; 29:1617-1623
  • 4[2]Maze M,Bass NM.Anesthesia and the Hepatobiliary System.In:Miller RD.Anesthesia.5th ed.Edinburgh:Churchill Livingstone,2000:1960-1973
  • 5[3]Ngai SH.Effects of anesthetics on various organs.N Engl J Med 1980; 302:564-566
  • 6[4]Srrunin L.Anesthetic management of patients with liver disease.In:Millward-Sadler GH,Wright R,Arthur MJ.Liver and Biliary Disease.London:Saunders,1992:1381-1391
  • 7[5]Batchelder BM,Cooperman LH.Effects of anesthetics on splanchnic circulation and metabolism.Surg Clin North Am 1975; 55:787-794
  • 8[6]Gelman S.General anesthesia and hepatic circulation.Can J Physiol Pharmacol 1987; 65:1762-1779
  • 9[7]Walton B,Simpson BR,Strunin L,Doniach D,Perrin J,Appleyard AJ.Unexplained hepatitis following halothane.Br Med J 1976; 1:1171-1176
  • 10[8]Kenna JG.Immunoallergic drug-induced hepatitis:lessons from halothane.J Hepatol 1997; 26 Suppl 1:5-12

共引文献14042

同被引文献12

  • 1白平平,朴云峰,秦俊杰.终末期肝病模型及Child-Pugh分级对肝硬化患者的短期预后分析[J].临床肝胆病杂志,2007,23(3):193-194. 被引量:2
  • 2吕晓辉,刘红波,宋敏,王炳元.终末期肝病模型对失代偿期肝硬化患者预后的回顾性分析[J].世界华人消化杂志,2007,15(9):960-963. 被引量:14
  • 3HUO Tt, Wang YW, Yang YY, et al. Model for end-stage liver disease score to serum sodiam ratio index as a prognostic predicter and its correlation with portal pressure in patients with liver cirrhosis[J]. Lever Int, 2007, 27(4): 498-506.
  • 4Biggins SW, Kim WR, Terrault NA, et al. Evidence based in corporation of serum sodium cincentration into MEID[J]. Gastroenterology, 2006, 130(6): 1652-1660.
  • 5Kamath PS, Wiesner RH, Malinchic M, et al. A model to predict survival in patients with end stage liver disease[J]. Hepatology, 2001, 33(2): 464-470.
  • 6Wang VW, Chim AM, Wong GL, et al. Performance of the new MELD-Na score in predicting 3-month mortality in Chinese patients with chronic hepatitis[J]. Liver Transpl, 2007, 13(9): 1228- 1335.
  • 7Heuman DM, Abou-Assi SG, Habib A, et al. Persistence ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death[J]. Hepatology, 2004, 40(4): 802-810.
  • 8Wong VW, Chim AM, Wong GL, et aI.Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B[J]. Liver Tranpl, 2007, 13(9): 1228-1235.
  • 9王文虎,王鲁文,龚作炯.肝硬化腹水患者低钠血症与病情严重程度的关系[J].临床内科杂志,2007,24(9):636-637. 被引量:5
  • 10毕春山,展玉涛.终末期肝病模型评分联合血清钠预测肝硬化预后的研究[J].山东医药,2008,48(19):9-10. 被引量:2

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部